Diabetes mellitus is a global epidemic affecting over 380 million individuals worldwide. Despite the improvements in diabetes therapy over the past two decades, the current therapy for both Type 1 and Type 2 diabetes relies on chronic insulin use. Moreover, none of the currently available insulin treatments are glucose-responsive and capable of mimicking the dynamic functionality of the pancreas. The overall objective of this project is to investigate the in vivo applications of smart insulin conjugates with glucose-mediated potency and bioavailability.

I am a senior studying Chemical-Biological Engineering. I have been with my project for the the past year and a half. I chose to pursue a SuperUROP because I knew that that the program would provide me with opportunities to improve my skill not only as a researcher, but also as a writer and a presenter.